Nabriva Therapeutics plc

CIK 1641640 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Nabriva Therapeutics plc.

Recent SEC filings

FiledFormAccession number
Oct 25, 202315-12G0001104659-23-111352
Oct 24, 2023EFFECT9999999995-23-003076
Oct 20, 2023S-8 POS0001104659-23-110234
Oct 20, 2023S-8 POS0001104659-23-110235
Oct 20, 2023S-8 POS0001104659-23-110238
Oct 20, 2023S-8 POS0001104659-23-110233
Oct 20, 2023S-8 POS0001104659-23-110232
Oct 20, 2023S-8 POS0001104659-23-110239
Oct 20, 2023POS AM0001104659-23-110245
Oct 20, 2023S-8 POS0001104659-23-110237
Oct 20, 2023S-8 POS0001104659-23-110236
Oct 19, 202310-Q0001558370-23-016524
Sep 8, 202325-NSE0001354457-23-000651
Aug 14, 2023NT 10-Q0001104659-23-091317
Jul 31, 20238-K0001104659-23-085605
Jul 24, 20238-K0001104659-23-083250
Jul 10, 202330001104659-23-079722
Jul 10, 202330001104659-23-079724
Jul 7, 20238-K0001104659-23-079156
Jun 1, 20238-K0001104659-23-067071
May 22, 202310-Q0001558370-23-010302
May 15, 2023NT 10-Q0001104659-23-060936
Apr 17, 202310-K0001558370-23-006062
Mar 31, 2023NT 10-K0001104659-23-040216
Feb 6, 20238-K0001104659-23-010788